Errata by unknown
Focus - Banking on Tissues
Name ofstudy No. ofsamples Type ofsample Endpoint
National Human Adipose Tissue Survey (NHATS) 12,000 fattissues pesticide residues
National Health and Nutrition Examination Surveys (NHANES) 20,000 blood mostly nutrition
National Human Exposure Assessment Survey (NHEXAS) about950 blood, urine, hair, fingernail metals, volatile organics,
pesticides, PAHs
Breast and prostate cancer studies (Helzlsouer) 25,000 blood organochlorines and breast
cancer, cadmium and
prostate cancer
Harvard University Physicians Study 15,000 blood PAH biomarkers, gene metabolism
and carcinogens
Uranium miner studies (Taylor) 52 squamous cell cancers mutation in the p53tumor
suppressor gene
Lung cancer study (Taylor) 25 asbestos-associated mutations in smoking-associated
lung tumors tumors
Aflatoxin and liver cancer study (Groopman) 18,000 serum and urine interaction between aflatoxin and
hepatitis B in liver cancer
to link human specimens with individuals,
or that a new informed consent must be
obtained every time a researcher studies a
new gene.
In their rush to protect research sub-
jects, says Caporaso, Steinberg and others
are confusing the big risks to individuals of
having a BRCAI breast cancer gene or
HNPCCcolon cancer gene with risks from
metabolic polymorphisms that are insignifi-
cant from the standpoint ofthe individual,
yet important to public health. "It would
be farfetched to think that [genes for car-
cinogen-metabolizing proteins] would have
health implications for families," says
Everson. But the proposed standards would
hamstring this research, says Schulte.
The standard ofanonymity is impossi-
ble to achieve without dumbing informa-
tion on each individual down to useless-
ness, some researchers say. It only takes a
few pieces of information such as grade
and stage of tumor, age at resection, race,
and smoking habit to make possible a
definitive identity, even if all links in the
database have been cut. "As an example of
anonymity," says Steinberg, " a set ofsuch
parameters should identify at least three
people.
"Requiring consent for every new gene
to be studied from a sample is untenable,"
asserts Caporaso, "in that it does not appear
to serve either the individual's interest or
those of science. The cost is prohibitive. If
it's a population-based cohort . .. and you
want to write to every person and saywe are
going to test a genetic marker, this is what it
means: with a cohort of100,000 people, the
cost is conservatively in the millions."
But in dealing with human subjects, it
is important to err on the side of caution,
Steinberg asserts, alluding to the medical
establishment's past paternalism. "We are
the servants of the public. We have to be
very sensitive to issues ofimportance to the
public . . . and we have to deal with their
perception ofrisk."
The JAMA authors also recommended
"enactment of more general legislation to
ensure that no person or institution be able
to obtain access, even by court order or
subpoena, to either the samples used in
research or the specific results of research
performed on such samples." Their reason-
ing was that "although protection may
already be provided by certificates ofconfi-
dentiality, sources are entitled to this high-
er level of protection in exchange for
allowing their samples to be used for
research."
The Office for Protection from
Research Risks at NIH might develop its
own guidance, and the new National
Bioethics Advisory Commission being
established by President Clinton could
issue guidance, says John Miller, the
office's deputy director. For the moment at
least, such guidance remains the province
ofindividual institutional review boards.
The controversy over informed consent
has left those who bank on tissues holding
their breath. Tissue banking has proven its
value as a versatile method ofstudying the
impact ofenvironmental contamination on
human health, and for contributing infor-
mation for environmental policy-making.
Questions such as deciding how to con-
duct a study, which tissues to collect, and
how best to store them can be difficult to
answer, but usually yield to creativity, hard
work, and money. Researchers fear that
current issues surrounding informed con-
sent might not be nearly so tractable. How
this controversy plays out will have a pro-
found impact on a crucial area ofenviron-
mental research.
David Holzman
ERRATA
The second paragraph of the second
column on page 23 of the article The
Attack ofAsthma in the January 1996
issue ofEHP(104:1) mistakenly attrib-
utes statisics about Puerto Rican chil-
dren and asthma to the New York
Times. The information is taken from
an article that appeared in the April
1993 issue of the AmercanJurnal of
Public alh (83:4), nti Reported
Asthma amon Puerto Rican, Mexican-
American, and Cuban Children, 1982
through 1984. The statistics were also
incorretl identified as the rates of
asthma among Puerto Rican, Mexican
American, Cuban, black, and white
chide betwen 1982 aindl9. Th
should have been identified as the per
centaeof childii who have eve h
asthma. Als in t ais E ed, the
date at the bottonLo the ;i WtcIn
on pg 23 mistakly ir ce
1976 And 1908." Th4eteehould
read "1980."
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